Article Details
Retrieved on: 2024-07-06 17:15:14
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses recent FDA actions in the biotech field, including the expanded approval of Sarepta Therapeutics' DMD gene therapy (Elevidys) and other approvals, responses, and designations impacting gene and cell therapies. These updates align with the key concept 'biotech' and relevant tags.
Article found on: www.cgtlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here